| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |